*This is Part 4 of our series on Vega Health's business model. We've covered infrastructure, marketplace access, and the importance of real monitoring. In the final piece of this series, we'll discuss how Vega Health sources the models on our Marketplace: by creating pathways for proven innovations to reach the healthcare delivery organizations that need them most.*
The Healthcare AI Distribution Problem
"If it worked here, why can't it scale everywhere?"
It's the healthcare AI paradox. The best products – those developed by those closest to care, with validated outcomes – struggle to reach the organizations that need them most. And the products with the widest distribution aren't always the best solutions.
For innovators working within health systems to develop solutions, the main culprit is the digital divide. The largest, most advanced health systems have invested years (and significant sums of money) developing and integrating AI models that help them deliver better patient care or more efficient operations. These developers have navigated the technical challenges, integrated solutions into workflows successfully, and objectively measured impact on clinical outcomes or reduced costs.
After a successful implementation, innovators at these health systems may present at an academic conference, publish the results in a peer-reviewed journal, and then move on to solving the next problem.
Meanwhile, commercial AI solutions with strong clinical validation face similar distribution challenges. Even when a company has achieved real-world validation and proven clinical impact, reaching beyond early adopter sites requires distribution infrastructure that most don't have.
Across the country, health systems continue to struggle with the same issues these solutions could solve.
It's a waste. For healthcare. For clinicians, administrators, and patients who could benefit. It's a missed opportunity for the organizations and companies that made the original investments. And it's the problem Vega Health exists to solve.
The best healthcare AI products – those developed by those closest to care, with validated outcomes – struggle to reach the organizations that need them most.
Why Proven Innovations Struggle to Scale
First: scaling is hard. Even when a solution performs ideally at one health system, it can't simply be lifted and dropped into a new environment.
Effective AI performance requires painstaking data curation and normalization, workflow integration, clinical staff buy-in, continuous monitoring, and more. To achieve similar impact at a new location, these capabilities need to be rebuilt and that purchasing health system needs a platform on which to host the solution (want to learn more? Check out Part 1 of our series on foundational infrastructure).
Second, health systems aren't software companies. Teams who build AI solutions are focused on solving problems for their organizations, not commercializing products. They're clinicians and data scientists who want to improve care. Most don't leave their jobs to become entrepreneurs. They don't want to be in the software sales business; they want to solve healthcare problems.
Commercially-developed products face similar scaling challenges, even when they've invested in clinical validation. Building proven AI is one thing. Building the distribution and integration infrastructure, implementation expertise, and ongoing monitoring capabilities to serve hundreds of health systems is entirely different. Most companies - even those with validated solutions - lack the resources, expertise, and relationships to scale effectively.
Finally, even when academic organizations or health systems want to share their innovations, the paths forward are unclear or limiting. Spin out a point solution startup? Exclusively license to an existing vendor, locking into a single go-to-market path? Open source the code and hope interested organizations can implement it? Each option has significant downsides and requires expertise most don't have.
So proven innovations stay trapped. Health systems that built solutions get local value. Commercial companies with validated products struggle to reach beyond a few early adopters. Everyone else keeps reinventing the wheel or settling for unvalidated solutions. And the organizations that made the original investments get limited return beyond local impact.
There should be a better model for bringing proven innovations to scale. With Vega Health, there is.
How Vega Health Expands Distribution for Proven AI
At Vega Health, our business model solves this problem. We're not a validation service or credentialing body; we're a distribution partner with foundational infrastructure, comprehensive implementation support, and monitoring capabilities. If you've developed an AI model that delivers real-world outcomes, we want to help you reach the organizations that need it.
Our Partnership Model
For health system innovators: You retain full ownership of your intellectual property and share in revenue when other organizations purchase your model through our marketplace. Our licensing model is non-exclusive, and revenue share terms are applied consistently across partners. This structure is foundational to our commitment to customers: our only incentive is to match them with AI solutions that deliver the best outcomes in their environment.
For commercial developers: We provide distribution infrastructure and implementation expertise you'd otherwise need to build internally, enabling your product to reach health systems through our platform while we handle the technical complexity of integration, local evaluation, and monitoring. Our partnership model is similarly non-exclusive, and revenue share terms are consistent.
Your team doesn't need to become a services organization managing implementations, maintenance, and monitoring across dozens of different environments.
You provide what's already in line with your expertise: the innovation itself, documentation of how it works, clinical and technical expertise to support implementations, and real-world evidence of its impact.
What Makes Our Marketplace Different
Every AI model on the Vega Health Marketplace must meet three non-negotiable criteria: real-world implementation, peer-reviewed validation, and transparency through the Model Facts Label.
We take proven innovations and bring them into our curated marketplace. But "curated" means something at Vega Health. Every AI model on the Vega Health Marketplace - whether developed within a health system or by a commercial company - must meet three validation criteria:
One, the model must have been implemented in a real-world clinical context and demonstrated results. Not just in-silico performance—actual clinical or operational deployment with measured outcomes.
Two, that evidence of success must be validated through publication in a peer-reviewed academic journal or as a pre-print publication undergoing peer review. This ensures independent verification of performance claims and holds all solutions to the same standard of evidence.
Three, the developer must complete the Model Facts Label developed by the Health AI Partnership. This standardized documentation gives health systems transparency about the model's development, validation, and intended use before they make any purchasing decision.
These aren't negotiable. They apply equally to innovations from innovators and researchers working within health systems, solutions from innovative commercial companies, and everything in between. This is what distinguishes our marketplace from vendor catalogs or marketplaces with minimal quality controls.
The Vega Health Platform handles data curation, standardized runtime environments, and comprehensive monitoring—so customers don't need to rebuild infrastructure for each solution, and models don't need to be customized for each environment.We integrate solutions with each customer's EHR and clinical systems, conduct local validation (comprehensive retrospective evaluation on their historical data) to understand what model works best before any go-live, then configure workflows to maximize adoption and outcomes and train end-users.
Because we're not locked into promoting any single solution, we provide objective performance data to both customers and model developers. We don't take payment from developers for marketplace placement. We don't hide performance data when solutions underperform. If a solution isn't delivering expected results in a new environment, we help diagnose whether it's a technical issue, workflow integration challenge, or adoption problem - and we give the data and insights back to customers and innovators to improve future development.
The Benefits Beyond Revenue
For health system innovators, commercialization creates new revenue streams that matter. AI development is expensive, and generating return on those investments makes it easier to continue or expand innovation work.
But the benefits extend beyond financial returns. When your solution scales to other organizations, you gain valuable data about how it performs in different contexts. You learn what works universally and what needs local adaptation. You build a network of organizations using your innovation who can share insights and drive collective improvement.
For commercial developers, our platform provides distribution infrastructure and implementation expertise you'd otherwise need to build internally. You reach health systems through established relationships and proven integration capabilities, accelerating time-to-market and reducing customer acquisition costs while maintaining quality standards.
For both: Your organization's reputation as a healthcare innovator grows. That helps attract top technical and clinical talent. It creates partnership opportunities. It positions you as a contributor to a growing ecosystem of validated solutions.
Most importantly, your innovation achieves impact at scale. The solution that improved care for an initial set of patients now improves care for patients across the country. That's why most people get into healthcare innovation in the first place.
Not Every Organization Builds (And That's Ok)
Not every health system will develop AI solutions worth commercializing. Many organizations will primarily implement proven solutions from others, optimizing them for local contexts and generating value through effective integration.
That's perfectly valid. Success with healthcare AI doesn't require building a full development team. It requires implementing what works and monitoring to ensure solutions continue working in your environment.
But some health systems will build something exceptional. Many already have. When that happens, those organizations shouldn't face a binary choice between keeping innovation internal or spinning up a software company. There should be a path to scale that innovation while maintaining focus on the core mission: delivering excellent healthcare.
Similarly, commercial developers with proven, validated solutions should benefit from infrastructure that enables distribution while maintaining the quality and monitoring standards healthcare demands.
That's what Vega Health provides. A way for health system innovators to move from local implementation to national impact without becoming something they're not. A way for commercial developers to reach healthcare delivery organizations through proven distribution channels and implementation expertise. All while maintaining the standards and objective monitoring that healthcare AI requires.
What Healthcare Needs
Healthcare AI needs better distribution infrastructure for proven innovations. Better ways to scale what actually works.
The best healthcare AI is being built by organizations and individuals who understand healthcare operations, have access to real clinical data, and are held accountable for patient outcomes. Leading academic medical centers. Innovative health systems. Commercial companies with deep healthcare expertise and commitment to real-world validation. Individual healthcare innovators who have dedicated their careers to solving these problems.
These organizations and individuals need a partner who can help them scale - not a credentialing service to gatekeep the market, or a vendor marketplace with minimal quality controls, but a distribution partner backed by implementation expertise, comprehensive monitoring, and objectivity that aligns our incentives with customers finding what actually works.
Bringing It All Together
Over this four-part series, we've walked through what healthcare AI implementation actually requires: infrastructure that scales, access to a curated marketplace of proven solutions, objective monitoring that proves what works, and—for those developing leading innovations—distribution pathways that help them achieve impact at scale.
These aren't separate capabilities. They're interconnected pieces of a model we've designed at Vega Health to make AI work in healthcare. The platform equips health systems with foundational infrastructure (Part 1) to evaluate and implement solutions from the Vega Health marketplace (Part 2). Comprehensive monitoring across four dimensions (Part 3) proves those solutions deliver value in your environment. And our distribution model (Part 4) creates pathways for continued innovation while scaling what works. Each piece reinforces the others: infrastructure enables marketplace access, the marketplace provides validated models, monitoring proves they work, and our distribution approach scales proven innovations.
Ready to scale your innovation—or find solutions that actually work?
If you've developed AI solutions with demonstrated real-world impact, or if you're searching for validated solutions for your health system, let's connect.
*Email: info@vegahealth.com*
Message us directly
